DCF — OZARKS MEDICAL CENTER
Enterprise Value: $-128.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-128.9M
Enterprise Value
$-43.1M
PV of Cash Flows
$-85.8M
PV of Terminal Value
$-138.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $150.1M | $-6.8M | -4.0% | $-13.1M | $-11.9M |
| Year 2 | $154.7M | $-5.4M | -3.0% | $-12.0M | $-9.9M |
| Year 3 | $159.3M | $-4.0M | -2.0% | $-10.7M | $-8.1M |
| Year 4 | $164.1M | $-3.3M | -2.0% | $-10.2M | $-7.0M |
| Year 5 | $169.0M | $-3.0M | -2.0% | $-10.1M | $-6.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-128.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$145.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999998285041765
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5